Oncologist, Specialist in skin cancer treatment
Endocrinologist
Dr. Nuri Ceydeli is a gynecologist and obstetrician with over 15 years of experience. He is a graduate of Istanbul University Istanbul Medical School (1995) and Istanbul University Cerrahpaşa Medical School (2002), and is a member of the Turkish Gynecology and Obstetrics Society, Turkish Gynecologic Oncology Society, Surgical Infection Association, and AAGL.
Oncologist, Gastroenterologist
Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.
Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.
Endocrinologist
Prof. Dr. med. Karl J. Oldhafer is a Senior Consultant of the Department of General and Abdominal Surgery and Surgical Oncology at the Abdominal Medical Center of the Barmbek Asklepios Hospital and is a specialist in hepatic surgery. His medical interests include radioservice computer-navigated liver surgery, metastasis surgery, surgery using the ultrasonic knife, minimally invasive abdominal surgery, hepatobiliary surgery, and pancreatic surgery.
One of the best cancer specialists in Europe, educator, and cancer researcher, President of the Central European Cooperative Oncology Group (CECOG).
Has published over 600 scientific papers on cancer treatment.
Memberships
Academic degree
Ph.D
International experience
Assoc. Prof. Dr. Ayşe Sinangil is a nephrologist with expertise in kidney failure. She has authored 30 international publications. She has also presented at 19 international scientific meetings.
Dr. Sinangil graduated from Istanbul University Cerrahpaşa Faculty of Medicine. She completed her specialization at Okmeydanı Training and Research Hospital in 2004. In 2012, she finished a minor specialization at Istanbul Şişli Etfal Training and Research Hospital. She is a member of the Turkish Society of Nephrology, ERA, and EDTA. Dr. Sinangil is dedicated to ongoing professional development in nephrology.
Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology
Education:
Professional Experience:
Clinical Trials, Courses, Certifications:
Clinical Trials:
Courses:
Certifications:
Memberships:
Dr. Harald Rosen is a leading abdominal surgeon. He specializes in endocrine, gastrointestinal, liver, colon, and bariatric surgeries. His expertise includes complex procedures such as sleeve gastrectomy and gastric anastomosis. Dr. Rosen is known for his research on improving the quality of life for rectal cancer patients after surgery. He also has a strong academic background in surgical oncology, with a focus on gastroenterology and breast cancer.
Dr. Rosen is President of the European Society of Surgery. He is also a Professor of Surgery at Vienna Medical School. He is accredited by the European Council for Surgical Qualifications and the Austrian Medical Council. Dr. Rosen has performed over 5,000 advanced surgeries with excellent results. He has published widely and is often invited as a visiting professor around the world.
Dr. Saban Sec is a medical oncologist with experience at leading hospitals, including Haseki Training and Research Hospital, Prof. Dr. Cemil Taşcıoğlu City Hospital, and Bahçelievler Medikalpark Hospital. He currently represents specialist physicians in the Turkish Medical Oncology Association. He is also a member of the Istanbul Medical Chamber and the Turkish Medical Oncology Association.
Dr. Sec treats breast, lung, gastrointestinal, prostate, urogenital, head and neck cancers, as well as sarcomas and rare tumors. He has published many peer-reviewed articles on cancer prognosis, treatment outcomes, and survival rates. His research includes studies with large patient groups, such as 138 patients with HER2-positive metastatic gastric cancer. Dr. Sec focuses on prognostic factors and treatment responses in different cancers. He is dedicated to improving cancer care.
Professor of oncosurgery and proctology